StageZero Life Sciences (GNWSD) Stock Chart & Stock Price History $0.03 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock StageZero Life Sciences Stock Price Performance The StageZero Life Sciences (GNWSD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 139.06%, with a year-to-date return of 1,692.94%. In the past month, the stock has increased 856.23%, reflecting recent market activity. As of the latest close, StageZero Life Sciences traded at $0.02 with a market cap of $1.18 million and volume of 4,708 shares. Receive GNWSD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+19.53%1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date Performance+1,692.94%1 Year PerformanceN/A GNWSD Stock Chart for Sunday, June, 22, 2025 GNWSD Chart by TradingView StageZero Life Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$0.02$0.02$0.03$0.024,708 shs$1.18 million06/19/2025$0.02$0.02$0.03$0.024,708 shs$1.18 million06/18/2025$0.02$0.02$0.03$0.024,708 shs$1.18 million06/17/2025$0.02$0.02$0.03$0.024,708 shs$1.18 million06/16/2025$0.02$0.02$0.03$0.024,708 shs$1.18 million06/13/2025$0.00$0.03+918.00%$0.03$0.036,418 shs$1.50 million05/21/2025$0.00$0.00$0.00$0.00881 shs$147,000.00 Related Companies Mustang Bio Stock Chart Sonoma Pharmaceuticals Stock Chart Matinas Biopharma Stock Chart CNS Pharmaceuticals Stock Chart Azitra Stock Chart Else Nutrn Stock Chart CERo Therapeutics Stock Chart Dermata Therapeutics Stock Chart ATI Physical Therapy Stock Chart Sigyn Therapeutics Stock Chart Receive GNWSD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GNWSD) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredYour Guide to Outperforming the Market - Guaranteed.Join the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
